Anglo American plc (NGLB.DE) Fundamental Analysis & Valuation

FRA:NGLB • GB00B1XZS820

Current stock price

26.35 EUR
+0.2 (+0.76%)
Last:

This NGLB.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. NGLB.DE Profitability Analysis

1.1 Basic Checks

  • In the past year NGLB was profitable.
  • In the past year NGLB had a positive cash flow from operations.
  • Of the past 5 years NGLB 4 years were profitable.
  • In the past 5 years NGLB always reported a positive cash flow from operatings.
NGLB.DE Yearly Net Income VS EBIT VS OCF VS FCFNGLB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

  • The Return On Assets of NGLB (-4.73%) is worse than 82.93% of its industry peers.
  • Looking at the Return On Equity, with a value of -14.78%, NGLB is doing worse than 85.37% of the companies in the same industry.
  • The Return On Invested Capital of NGLB (6.26%) is better than 63.41% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NGLB is in line with the industry average of 8.58%.
Industry RankSector Rank
ROA -4.73%
ROE -14.78%
ROIC 6.26%
ROA(3y)0.8%
ROA(5y)3.74%
ROE(3y)0.95%
ROE(5y)8.34%
ROIC(3y)9.27%
ROIC(5y)11.68%
NGLB.DE Yearly ROA, ROE, ROICNGLB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

  • NGLB has a Operating Margin of 18.13%. This is in the better half of the industry: NGLB outperforms 70.73% of its industry peers.
  • NGLB's Operating Margin has declined in the last couple of years.
  • NGLB's Gross Margin of 45.82% is fine compared to the rest of the industry. NGLB outperforms 73.17% of its industry peers.
  • In the last couple of years the Gross Margin of NGLB has remained more or less at the same level.
Industry RankSector Rank
OM 18.13%
PM (TTM) N/A
GM 45.82%
OM growth 3Y-23.9%
OM growth 5Y-2.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.4%
GM growth 5Y1.14%
NGLB.DE Yearly Profit, Operating, Gross MarginsNGLB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

4

2. NGLB.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NGLB is still creating some value.
  • The number of shares outstanding for NGLB remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for NGLB has been reduced compared to 5 years ago.
  • Compared to 1 year ago, NGLB has a worse debt to assets ratio.
NGLB.DE Yearly Shares OutstandingNGLB.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
NGLB.DE Yearly Total Debt VS Total AssetsNGLB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 2.18 indicates that NGLB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.18, NGLB is in line with its industry, outperforming 58.54% of the companies in the same industry.
  • NGLB has a debt to FCF ratio of 7.31. This is a slightly negative value and a sign of low solvency as NGLB would need 7.31 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 7.31, NGLB perfoms like the industry average, outperforming 56.10% of the companies in the same industry.
  • A Debt/Equity ratio of 0.78 indicates that NGLB is somewhat dependend on debt financing.
  • NGLB has a Debt to Equity ratio of 0.78. This is in the lower half of the industry: NGLB underperforms 75.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 7.31
Altman-Z 2.18
ROIC/WACC0.68
WACC9.19%
NGLB.DE Yearly LT Debt VS Equity VS FCFNGLB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

  • NGLB has a Current Ratio of 1.86. This is a normal value and indicates that NGLB is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of NGLB (1.86) is better than 63.41% of its industry peers.
  • A Quick Ratio of 1.29 indicates that NGLB should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.29, NGLB is in the better half of the industry, outperforming 75.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.29
NGLB.DE Yearly Current Assets VS Current LiabilitesNGLB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1

3. NGLB.DE Growth Analysis

3.1 Past

  • The earnings per share for NGLB have decreased strongly by -33.33% in the last year.
  • The Earnings Per Share has been decreasing by -9.94% on average over the past years.
  • Looking at the last year, NGLB shows a very negative growth in Revenue. The Revenue has decreased by -10.97% in the last year.
  • Measured over the past years, NGLB shows a decrease in Revenue. The Revenue has been decreasing by -1.79% on average per year.
EPS 1Y (TTM)-33.33%
EPS 3Y-39.23%
EPS 5Y-9.94%
EPS Q2Q%-47.57%
Revenue 1Y (TTM)-10.97%
Revenue growth 3Y-13.08%
Revenue growth 5Y-1.79%
Sales Q2Q%-15.83%

3.2 Future

  • Based on estimates for the next years, NGLB will show a small growth in Earnings Per Share. The EPS will grow by 4.65% on average per year.
  • NGLB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.87% yearly.
EPS Next Y-13.88%
EPS Next 2Y7.11%
EPS Next 3Y11.89%
EPS Next 5Y4.65%
Revenue Next Year-12.33%
Revenue Next 2Y-7.45%
Revenue Next 3Y-3.09%
Revenue Next 5Y-3.87%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NGLB.DE Yearly Revenue VS EstimatesNGLB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
NGLB.DE Yearly EPS VS EstimatesNGLB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

3

4. NGLB.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.96, which indicates a rather expensive current valuation of NGLB.
  • The rest of the industry has a similar Price/Earnings ratio as NGLB.
  • The average S&P500 Price/Earnings ratio is at 25.23. NGLB is valued slightly cheaper when compared to this.
  • NGLB is valuated rather expensively with a Price/Forward Earnings ratio of 22.02.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of NGLB is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.42, NGLB is valued at the same level.
Industry RankSector Rank
PE 18.96
Fwd PE 22.02
NGLB.DE Price Earnings VS Forward Price EarningsNGLB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • NGLB's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NGLB is cheaper than 60.98% of the companies in the same industry.
  • NGLB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NGLB is cheaper than 73.17% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.29
EV/EBITDA 6.3
NGLB.DE Per share dataNGLB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.11%
EPS Next 3Y11.89%

2

5. NGLB.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.90%, NGLB has a reasonable but not impressive dividend return.
  • NGLB's Dividend Yield is a higher than the industry average which is at 1.68.
  • NGLB's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.9%

5.2 History

  • The dividend of NGLB decreases each year by -5.62%.
Dividend Growth(5Y)-5.62%
Div Incr Years0
Div Non Decr Years0
NGLB.DE Yearly Dividends per shareNGLB.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of NGLB are negative and hence is the payout ratio. NGLB will probably not be able to sustain this dividend level.
DP-33.44%
EPS Next 2Y7.11%
EPS Next 3Y11.89%
NGLB.DE Yearly Income VS Free CF VS DividendNGLB.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B 10B

NGLB.DE Fundamentals: All Metrics, Ratios and Statistics

Anglo American plc

FRA:NGLB (5/30/2025, 7:00:00 PM)

26.35

+0.2 (+0.76%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-24
Earnings (Next)07-31
Inst Owners68.45%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap35.25B
Revenue(TTM)27.29B
Net Income(TTM)-3.07B
Analysts73.33
Price Target29.71 (12.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.9%
Yearly Dividend0.67
Dividend Growth(5Y)-5.62%
DP-33.44%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.97%
PT rev (3m)-8.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-18.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.82%
Valuation
Industry RankSector Rank
PE 18.96
Fwd PE 22.02
P/S 1.49
P/FCF 16.29
P/OCF 5.01
P/B 1.95
P/tB 2.05
EV/EBITDA 6.3
EPS(TTM)1.39
EY5.28%
EPS(NY)1.2
Fwd EY4.54%
FCF(TTM)1.62
FCFY6.14%
OCF(TTM)5.26
OCFY19.97%
SpS17.72
BVpS13.48
TBVpS12.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.73%
ROE -14.78%
ROCE 8.89%
ROIC 6.26%
ROICexc 7.34%
ROICexgc 7.49%
OM 18.13%
PM (TTM) N/A
GM 45.82%
FCFM 9.13%
ROA(3y)0.8%
ROA(5y)3.74%
ROE(3y)0.95%
ROE(5y)8.34%
ROIC(3y)9.27%
ROIC(5y)11.68%
ROICexc(3y)10.68%
ROICexc(5y)13.58%
ROICexgc(3y)11.14%
ROICexgc(5y)14.35%
ROCE(3y)13.18%
ROCE(5y)16.62%
ROICexgc growth 3Y-35.05%
ROICexgc growth 5Y-7.67%
ROICexc growth 3Y-34.05%
ROICexc growth 5Y-6.65%
OM growth 3Y-23.9%
OM growth 5Y-2.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.4%
GM growth 5Y1.14%
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 7.31
Debt/EBITDA 2.02
Cap/Depr 182.68%
Cap/Sales 20.56%
Interest Coverage 5.81
Cash Conversion 101.04%
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.29
Altman-Z 2.18
F-Score5
WACC9.19%
ROIC/WACC0.68
Cap/Depr(3y)221.62%
Cap/Depr(5y)211.97%
Cap/Sales(3y)19.39%
Cap/Sales(5y)18.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.33%
EPS 3Y-39.23%
EPS 5Y-9.94%
EPS Q2Q%-47.57%
EPS Next Y-13.88%
EPS Next 2Y7.11%
EPS Next 3Y11.89%
EPS Next 5Y4.65%
Revenue 1Y (TTM)-10.97%
Revenue growth 3Y-13.08%
Revenue growth 5Y-1.79%
Sales Q2Q%-15.83%
Revenue Next Year-12.33%
Revenue Next 2Y-7.45%
Revenue Next 3Y-3.09%
Revenue Next 5Y-3.87%
EBIT growth 1Y-23.96%
EBIT growth 3Y-33.85%
EBIT growth 5Y-4.66%
EBIT Next Year43.63%
EBIT Next 3Y20.8%
EBIT Next 5Y5.96%
FCF growth 1Y411.5%
FCF growth 3Y-38.9%
FCF growth 5Y-3.13%
OCF growth 1Y24.74%
OCF growth 3Y-21.46%
OCF growth 5Y1.12%

Anglo American plc / NGLB.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for Anglo American plc?

ChartMill assigns a fundamental rating of 3 / 10 to NGLB.DE.


What is the valuation status of Anglo American plc (NGLB.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to Anglo American plc (NGLB.DE). This can be considered as Overvalued.


What is the profitability of NGLB stock?

Anglo American plc (NGLB.DE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of Anglo American plc (NGLB.DE) stock?

The Price/Earnings (PE) ratio for Anglo American plc (NGLB.DE) is 18.96 and the Price/Book (PB) ratio is 1.95.


What is the financial health of Anglo American plc (NGLB.DE) stock?

The financial health rating of Anglo American plc (NGLB.DE) is 4 / 10.